Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Coburn

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Nature Communications|August 15, 2019
Gut-associated IgA<sup>+</sup> immune cells regulate obesity-related insulin resistanceHelen Luck, Saad Khan, Justin H Kim, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
JCI Insight|February 8, 2022
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responsesElissa G Currie, Bryan Coburn, Elisa A Porfilio, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
The New England Journal of Medicine|November 20, 2024
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections, Nick Daneman, Asgar Rishu, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Nature Communications|August 15, 2019
Gut-associated IgA<sup>+</sup> immune cells regulate obesity-related insulin resistanceHelen Luck, Saad Khan, Justin H Kim, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
JCI Insight|February 8, 2022
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responsesElissa G Currie, Bryan Coburn, Elisa A Porfilio, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
The New England Journal of Medicine|November 20, 2024
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections, Nick Daneman, Asgar Rishu, et al.
Pageof 9